FDA panel recommends Pfizer vaccine for children ages 5 to 11
newsdepo.com
The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks.FDA panel recommends Pfizer vaccine for children ages 5 to 11
The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks. Read more